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The Kir4.1/Kir5.1 channel mediates basolateral K+ recycling in renal distal tubules; this process is
critical for Na+ reabsorption at the tubules. Mutations in Kir4.1 are associated with EAST/SeSAME
syndrome, a genetic disorder characterized by renal salt wasting. In this study, we found that
MAGI-1 anchors Kir4.1 channels (Kir4.1 homomer and Kir4.1/Kir5.1 heteromer) and contributes
to basolateral K+ recycling. The Kir4.1 A167V mutation associated with EAST/SeSAME syndrome
caused mistrafﬁcking of the mutant channels and inhibited their expression on the basolateral sur-
face of tubular cells. These ﬁndings suggest mislocalization of the Kir4.1 channels contributes to
renal salt wasting.
Structured summary of protein interactions:
Kir5.1 and Kir4.1 colocalize by ﬂuorescence microscopy (View interaction)
MAGI-1 physically interacts with Kir4.1 by anti bait coimmunoprecipitation (View interaction)
MAGI-1 physically interacts with Kir4.1 by anti bait coimmunoprecipitation (1, 2)
MAGI-1 physically interacts with Kir4.1 by pull down (View interaction)
Kir5.1 physically interacts with Kir4.1 by anti bait coimmunoprecipitation (View interaction)
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Genetic disorders have provided clues to the physiological
functions of several proteins. EAST/SeSAME syndrome is an autoso-
mal recessive genetic disorder characterized by a unique set of
symptoms: epilepsy (seizures), ataxia, sensorineural deafness,
mental retardation, and tubulopathy (electrolyte imbalance)
[1,2]. Mutations in KCNJ10 have been associated with this syn-
drome. KCNJ10 encodes Kir4.1, a member of the K+ channel family
known as inwardly rectifying K+ (Kir) channels. Kir4.1 channels
may comprise either Kir4.1 homomers or Kir4.1/Kir5.1 heteromers
[3]. Notably, Kir4.1 is expressed in rodents in the brain, ear, andkidney—the organs that are affected in humans with EAST/SeSAME
syndrome [4–6].
The KCNJ10 mutations associated with EAST/SeSAME syndrome
cause amino acid substitutions or carboxyl-terminal deletions in
Kir4.1 and, under experimental conditions, reduce the activity of
Kir4.1 channels [1,2,7–12]. With the exception of A167V, all other
identiﬁed KCNJ10mutations render Kir4.1 channels physiologically
inactive, thereby reducing K+ conductivity in the brain, ear, and kid-
ney; this disruption of K+ transport is likely responsible for the
symptoms of EAST/SeSAME syndrome [4–6]. In contrast, the
A167Vmutant forms a functional channel under experimental con-
ditions [7–9]. The homozygous A167V mutant shows approxi-
mately 60% residual activity, which is equivalent to the residual
activity of the channels of the other heterozygousmutations associ-
ated with EAST/SeSAME syndrome. This suggested that reduced K+
conductivity may not be solely pathogenic for the A167Vmutation.
Recently, the A167V mutation was noted to render the Kir4.1/
Kir5.1 heteromer nearly inactive in Xenopus oocytes [9]; this ﬁnd-
ing provided insights into the pathogenic role of the A167V
mutation in the tubulopathy observed in EAST/SeSAME syndrome.
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channel in the distal convoluted tubule (DCT) of rodent kidney
[13]. This basolateral K+ channel mediates recycling of the K+ taken
up by the basolaterally expressed Na+/K+ ATPase, and this recycling
provides the driving force for Na+ reabsorption at the DCT. Because
K+ recycling by the Kir4.1/Kir5.1 channel is indispensable to Na+
reabsorption, inactivation of this channel by the A167V mutation
causes renal salt wasting by reducing Na+ reabsorption [14].
However, inactivation of the Kir4.1/Kir5.1 heteromer by the
A167V mutation cannot explain the symptoms observed in the or-
gans where Kir4.1 does not form heteromeric complexes with
Kir5.1, such as the brain and ear [3,6]. In addition, the Kir4.1
(A167V)/Kir5.1 heteromer was found to retain its function in a
mammalian cell line [7]. In contrast to the almost complete loss
of function observed in Xenopus oocytes, the loss in COSm6 cells
was moderate. Thus, activity of the Kir4.1(A167V) channels varies
with the cell type: the channels are active in mammalian cells but
are inactive in Xenopus oocytes. This ﬁnding suggests that Kir4.1
(A167V) may form active basolateral K+ channels in tubular cells
and that the ﬁnding in Xenopus oocytes cannot provide evidence
for the pathogenesis of EAST/SeSAME syndrome.
We had previously reported that an anchor protein, membrane-
associated guanylate kinase with inverted domain structure-1
(MAGI-1), facilitates the basolateral localization of Kir4.1 channels
in tubular cells via direct interaction with Kir4.1 [15]. This ﬁnding
suggested that interaction with anchor proteins is indispensable
for functional expression of the Kir4.1 channels in several organs.
In this study, we explored the role of intracellular localization
of Kir4.1 channels in EAST/SeSAME syndrome-associated
tubulopathy.
2. Materials and methods
2.1. Antibodies
Polyclonal anti-Kir5.1 and anti-MAGI-1 antibodies were raised
and afﬁnity-puriﬁed as described previously [3,15]. Polyclonal
anti-Kir4.1 antibody (Sigma, Saint Louis, MO), anti-GFP antibodies
(Clontech Laboratories, Palo Alto, CA), PO-conjugated IgGs (Pierce,
Rockford, IL), Alexa Fluor 594 anti-rabbit IgG (Fab’)2 (Molecular
Probes, Eugene, OR), and ﬂuorescein isothiocyanate (FITC)-labeled
anti-rabbit IgG (Dako, Glostrup, Denmark) were purchased.
2.2. Immunohistochemistry
For immunohistochemical analysis of human kidney, renal
biopsy specimens with minor abnormalities were used with the
approval of the ethics committee of our institute. Frozen sections
(1–2 lm) were incubated in blocking buffer (Dako), and then with
the anti-Kir4.1 antibody followed by incubation with an excess
(1:50 dilution) of Alexa Fluor 594 anti-rabbit IgG (Fab’)2 to saturate
the antibody epitopes. After extensive washing, the sections were
incubated with the anti-Kir5.1 antibody and FITC-labeled anti-rab-
bit IgG (1:200). Anti-Kir4.1 and anti-Kir5.1 antibodies were used at
a ﬁnal concentration of 2 lg/mL. Microscopy was performed using
an Olympus model Bx50 (Olympus Medical Science, Tokyo, Japan).
2.3. Construction and transient expression of Kir channels
The coding sequences of human Kir4.1 and Kir5.1 (GenBank
Accession Number NG009379, NG016411 and NM018658) were
PCR-ampliﬁed from the human genome and inserted into mamma-
lian cell expression vectors pcDNA3 (Invitrogen, Carlsbad, CA) and
pEGFP-C1 (Clontech Laboratories), as described [16]. Point muta-
tions were introduced with the QuickChange™ Site-DirectedMutagenesis Kit (Stratagene, La Jolla, CA). The expression vectors
were transfected into Madin-Darby canine kidney (MDCK) II cells
and human embryonic kidney (HEK) 293T cells with Lipofect-
AMINE 2000 (Invitrogen). Cytology and immunoblotting were
performed 2–3 days after transfection.
2.4. Cytology
Cytological observation of MDCK II and HEK293T cells was
performed as described previously [16,17]. MDCK II cells were cul-
tured to conﬂuence on polycarbonate Millicell transwell ﬁlters
(Millipore, Bedford, MA) and expression of a tight junction protein,
ZO-1, was observed on the top of the lateral wall. Confocal micros-
copy was performed using a model LSM5 PASCAL microscope (Carl
Zeiss Co., Ltd.).
2.5. Immunoblotting and cell surface biotinylation
Immunoblotting, immunoprecipitation, and glutathione S-
transferase (GST) pull-down assays were performed as described
previously [3,18]. Cell surface biotinylation was performed as
described previously [18]. To detect the blotted channels, anti-
Kir4.1 (1 lg/mL), anti-Kir5.1 (0.8 lg/mL), or anti-GFP antibody
(0.2 lg/mL) was used in blocking buffer [80 mM NaCl, 50 mM
Tris–HCl (pH7.5), 4% (w/v) skim milk and 0.2% Triton X-100], and
the immunoreacted bands were detected by SuperSignal West
Dura (Pierce). Band intensity was quantiﬁed with NIH Image soft-
ware (National Institutes of Health, Bethesda, MD). The degree of
band intensity for mutant relative to that of the wild type was cal-
culated as the intensity of mutant divided by that of the wild type.
2.6. Statistical analysis
The degree of band intensity was expressed as the mean ± stan-
dard deviation (S.D.). Comparisons were performed by the paired
two-tailed Student’s t test. Probability values of P < 0.01 were
considered statistically signiﬁcant.
3. Results
3.1. Composition of the basolateral K+ channel in human DCT
We determined the composition of the basolateral K+ channels
in human renal tubules by the co-immunostaining method. For
this, we used anti-Kir4.1 and anti-Kir5.1 antibodies; the speciﬁci-
ties of these antibodies were conﬁrmed by immunoblotting (Sup-
plementary Fig. 1). Each antibody speciﬁcally recognized the
corresponding human Kir channel tagged with green ﬂuorescent
protein (GFP), and none of the antibodies cross-reacted with other
Kir channels. We also conﬁrmed the saturation of the ﬁrst antibody
with Alexa Fluor 594 IgG (Fab’)2 by no spill-over staining using
FITC without the second antibody (Supplementary Fig. 2). This
analysis revealed localization of Kir5.1 to the Kir4.1-expressing tu-
bules (Fig. 1). In these tubules, Kir5.1 and Kir4.1 showed basolat-
eral distribution. Kir5.1 immunostaining was also observed in
tubules not showing positive immunostaining for Kir4.1; in these
tubules, Kir5.1 showed clustered distribution.
3.2. Kir4.1/Kir5.1 heteromer formation and role of MAGI-I in
basolateral K+ channel expression
Co-localization of Kir4.1 and Kir5.1 to the basolateral side sug-
gests that the Kir4.1/Kir5.1 heteromer forms the predominant
basolateral K+ channel in human DCT, as it does in rodent DCT
[13]. Channel assembly at the basolateral side also seems to
Fig. 1. Expression of Kir4.1 and Kir5.1 in human kidney. Kir5.1 shows basolateral localization in tubules expressing Kir4.1 and clustered localization in tubules not-expressing
Kir4.1. In tubules expressing Kir4.1, Kir5.1 colocalizes with Kir4.1 (Inset: tubule indicated by arrowhead). Gl, glomerulus.
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MAGI-1 [15]. To verify heteromer formation and assembly with
MAGI-1, we examined the intracellular localization of the Kir chan-
nels in MDCK II cells, a renal distal tubular cell line intrinsically
expressing MAGI-1 (Fig. 2A). When expressed alone in sheets of
MDCK II cells, human Kir5.1 showed diffuse cytoplasmic localiza-
tion, whereas human Kir4.1 clustered on the basolateral side. Co-
expression with un-tagged human Kir4.1 induced basolateral
localization of the GFP-tagged human Kir5.1. Furthermore, we
investigated which subunit of the heteromer interacted with
MAGI-1 by immunoprecipitation. Although the anti-MAGI-1Fig. 2. Kir4.1 mediated basolateral localization of Kir4.1/Kir5.1 heteromer. (A)
Intracellular distribution of human Kir4.1 and Kir5.1 in MDCK II cells. GFP-tagged
human Kir4.1 (GFP-Kir4.1) and Kir5.1 (GFP-Kir5.1) show basolateral clusters (upper
panels) and diffuse cytoplasmic localization (middle panels), respectively. When co-
expressed with un-tagged human Kir4.1 (GFP-Kir5.1 + Kir4.1), heteromeric assem-
bly with Kir4.1 induces basolateral localization of GFP-Kir5.1 (lower panels).
Representative localization in sheet-formed MDCK II cells is shown. Each panel set
shows horizontal (upper) and vertical (lower) views. (B) Interaction of human
Kir4.1 with MAGI-1. GFP-Kir4.1 but not GFP-Kir5.1 co-precipitated with MAGI-1 (IP
anti-MAGI) in MDCK II cells. The panel shows a representative immunoblot with
anti-GFP antibody. (C) Heteromeric assembly of human Kir5.1 with human Kir4.1.
GFP-Kir4.1 co-expressed with un-tagged human Kir5.1 is co-immunoprecipitated
by the anti-Kir5.1 antibody (IP anti-Kir5.1), whereas GFP-Kir4.1 expressed alone is
not. The panel shows a representative immunoblot with anti-GFP antibody.antibody precipitated Kir4.1 in MDCK II cells expressing human
Kir4.1, it did not precipitate Kir5.1 in MDCK II cells expressing
human Kir5.1 (Fig. 2B). We also conﬁrmed heteromer formation
between human Kir4.1 and Kir5.1 by immunoprecipitation; in this
analysis, the anti-Kir5.1 antibody precipitated human Kir4.1 only
in the presence of Kir5.1 (Fig. 2C). These ﬁndings indicate that
Kir4.1 is the subunit that interacts with MAGI-1 and that hetero-
meric assembly with Kir4.1 enables the Kir4.1/Kir5.1 heteromer
to interact with MAGI-1, which facilitates expression of the baso-
lateral K+ channels.
3.3. Effect of KCNJ10 mutations associated with EAST/SeSAME
syndrome
Our ﬁndings suggest that the localization of Kir4.1 in MDCK II
cells can be used as a model for studying the effect of mutations
associated with EAST/SeSAME syndrome on expression of the
basolateral K+ channels in the DCT. We generated GFP-tagged
human Kir4.1 with mutations speciﬁc to EAST/SeSAME syndrome
and examined localization of these mutants in MDCK II cells
(Fig. 3A). In sheets of MDCK II cells, the R65P, T164I, and R297C
mutants clustered on the basolateral side, similar to wild-type
Kir4.1. In contrast, the G77R, C140R, A167V, and R199X mutants
showed diffuse cytoplasmic localization, with no preference for
either side of the cell.
Notably, in non-tubular cells, the A167V mutant forms func-
tional channels, while the G77R, C140R, and R199X mutants do
not [7–11]. These data suggested that the A167V mutant is
expressed on the cell surface in non-tubular cells but not in tubular
cells. To test this hypothesis, we analyzed the cell-surface expres-
sion of the A167V mutant in renal tubular MDCK II cells and non-
tubular HEK293T cells through cell-surface biotinylation at 4 C.
Under the assay conditions, channels expressed at the surface
would be biotinylated. In MDCK II cells, considerably fewer
A167V channels were biotinylated than wild-type channels
(Fig. 3B). In HEK293T cells, however, biotinylation of the A167V
and wild-type channels was similar (Fig. 4A). The degree of biotin-
ylation for the mutant relative to that for the wild type was
0.16 ± 0.04 (n = 4; P < 0.01) and 1.03 ± 0.17 (n = 4; P = 0.73) in
MDCK II and HEK293T cells, respectively.
We also conducted cell-surface biotinylation studies of the
R65P and G77Rmutants, which represented the mutants that show
basolateral localization in MDCK II cells and those that do not,
respectively (Figs. 3B and 4A). In MDCK II and HEK293T cells, the
R65P mutant was biotinylated to the same degree as the wild type,
but few of the G77R mutant channels were biotinylated. The
degree of biotinylation for the R65P mutant relative to that for
Fig. 3. Intracellular localization of EAST/SeSAME Kir4.1 mutants in MDCK II cells. (A) R65P, T164I, and R297C mutants show clusters of basolateral localization similar to the
wild type (Wt). In contrast, G77R, C140R, A167V, and R199X mutants show diffuse cytoplasmic localization. Representative distribution of GFP-tagged channels in sheet-
formed MDCK II cells is shown. Each panel set shows horizontal (upper) and vertical (lower) views. (B) Cell-surface biotinylation. Left panels show a representative
immunoblot of channels in cell lysates (Whole cell) and in Streptavidin precipitates (Biotin 4 C). Arrowheads indicate predicted sizes. Right bar graph shows the degree of
biotinylation relative to Wt. Values represent the mean ± S.D. (n = 3; ⁄P < 0.01).
Fig. 4. Intracellular localization of EAST/SeSAME Kir4.1 mutants in HEK293T cells. (A) Cell-surface biotinylation analysis. Left panels show a representative immunoblot of
channels in cell lysates (Whole cell) and in Streptavidin precipitates (Biotin 4 C). Arrowheads indicate predicted sizes. Right bar graph shows the degree of biotinylation
relative to the wild type (Wt). Values represent the mean ± S.D. (n = 5; ⁄P < 0.01). (B) Channel distribution. Whereas Wt and R65P form clusters, G77R and A167V show diffuse
and ﬁne-reticular localization, respectively. Representative localization of GFP-tagged channels is shown. Each panel set shows horizontal (upper) and vertical (lower) views.
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(n = 5; P = 0.28) in MDCK II and HEK293T cells, respectively. On
the other hand, the degree for the G77R mutant relative to that
for the wild type was 0.16 ± 0.09 (n = 3; P < 0.01) and 0.12 ± 0.04
(n = 5; P < 0.01) in MDCK II and HEK293T cells, respectively. Inter-
estingly, in HEK293T cells, the A167V mutant exhibited ﬁne retic-
ular cytoplasmic distribution, whereas the G77R mutant showed
diffuse cytoplasmic distribution (Fig. 4B). The wild type and R65P
mutant formed clusters in HEK293T cells, as they did in MDCK II
cells.
3.4. Role of the anchor protein MAGI-1 in EAST/SeSAME syndrome
The cell-surface biotinylation analysis showed that the A167V
mutant is expressed on the cell surface in non-tubular but not in
tubular cells. Because the interaction with MAGI-1 facilitates baso-
lateral localization of Kir4.1 in tubular cells, we investigated the
interaction between the A167V mutant and MAGI-1 in MDCK II
cells (Fig. 5A). The mutant interacted less with MAGI-1 than did
the wild type. Most of the mutant channels, which were expressed
as efﬁciently as wild type channels, were not immunoprecipitated
with MAGI-1. The degree of precipitation for the A167V mutant
relative to the wild type was 0.22 ± 0.05 (n = 5; P < 0.01). In con-
trast, when co-expressed with MAGI-1 in HEK293T cells, the mu-
tant interacted with MAGI-1 as efﬁciently as the wild type
(Fig. 5B). The degree of precipitation for the mutant relative to that
for the wild type was 1.32 ± 0.47 (n = 4; P = 0.22). Furthermore, the
mutant and wild type channels were pulled down equally well
with GST-fused MAGI-1 (Fig. 5C). The degree of pull down for the
mutant relative to that for the wild type was 1.41 ± 0.24 (n = 4;
P = 0.02).
4. Discussion
In this study, we found that in human kidney, Kir5.1 localized to
the basolateral side of Kir4.1-expressing tubules. This co-localiza-
tion suggested that the Kir4.1/Kir5.1 heteromer forms the predom-
inant basolateral K+ channel in human DCT as in rodent DCT [13],
although we could not investigate the properties of the basolateral
K+ current at human DCT. We also established that MAGI-1, an an-
chor protein for Kir4.1, facilitates the functional expression of
this channel at the basolateral side by interacting with Kir4.1.Fig. 5. Interaction of the wild type (Wt) and the A167V mutant with MAGI-1. Immunob
panels show representative results of channels in cell lysates (Input), the anti-MAGI-1 an
MAGI). Arrowheads indicate predicted sizes. Lower bar graphs show the degree of preci
(n = 4; ⁄P < 0.01).Furthermore, we observed reduced basolateral surface expression
of Kir4.1(A167V) channels. This reduction could be attributed to
the mistrafﬁcking of the Kir4.1/Kir5.1 heteromer, which blocked
the interaction between Kir4.1 and MAGI-1. In addition, this reduc-
tion in channel expression is likely responsible for the renal salt
wasting observed in the A167V mutation-associated EAST/SeSAME
syndrome.
Although Kir4.1 and Kir5.1 co-localized to the basolateral side
in Kir4.1-expressing tubules, this localization could be altered by
conditions in the kidney. We previously reported that phosphory-
lation of the PDZ-binding motif of Kir4.1 changed the intracellular
localization of the Kir4.1 channel; phosphorylation promoted cyto-
plasmic distribution and de-phosphorylation resulted in circum-
ferential distribution [15]. Therefore, kidney conditions that
affect Kir4.1 phosphorylation may disrupt localization of the baso-
lateral K+ channels. This disruption could impair basolateral K+
recycling and thus affect Na+ reabsorption at the DCT.
In human kidney, Kir5.1 expression was observed in tubules
lacking Kir4.1 expression. These tubules exhibited the properties
of proximal tubules, including a tall column and prominent brush
border, not of collecting ducts, which are characterized by a short
column and cobblestone-like epithelia. At the proximal tubules,
Kir5.1 may form heteromers with Kir2.1 and may participate in
K+ transport [19]; however, further studies are needed to elucidate
the role of Kir5.1 in these tubules.
At the DCT, basolaterally expressed Na+/K+ ATPase provides
the driving force for apical Na+ reabsorption through the Na+–Cl
cotransporter (NCC) [20]. Because the Na+/K+ ATPase induces
K+ inﬂux in exchange for Na+ efﬂux, K+ excretion—known as K+
recycling—is the rate-limiting step in Na+ reabsorption at the
DCT [14,21]. Therefore, functional defects in the basolateral K+
channel, caused by mistrafﬁcking of the channel, reduce K+ recy-
cling and cause salt wasting at the DCT. In this regard, the tubulop-
athy observed in EAST/SeSAME syndrome is indistinguishable from
that observed in Gitelman’s syndrome, a renal salt-wasting disor-
der caused by mutations in SLC12A3, which reduce Na+ transport
through the NCC [22].
Mutations associated with EAST/SeSAME syndrome reduce the
K+ conductivity of Kir4.1 channels under experimental conditions
[1,2,7–12]. All Kir4.1 mutants, except the A167V mutant, exhibit
less than 20% residual activity. These mutations reduce K+ recy-
cling at the DCT, leading to impaired Na+ reabsorption and thus saltlots of MDCK II (A) and HEK293T cells (B), and GST pull-down analysis (C). Upper
tibody precipitates (IP-MAGI), and the GST–MAGI-1 fusion protein precipitate (PD-
pitation for A167V mutant relative to that for Wt. Values represent the mean ± S.D.
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mately 60% residual activity, which was equivalent to the activity
expected in unaffected siblings of patients with the other EAST/
SeSAME syndrome mutations, and A167V heterozygosity had been
considered non-pathogenic [7,8]. However, A167V homozygosity
was noted in patients with EAST/SeSAME syndrome [9]. Although
strong inactivation of the Kir4.1/Kir5.1 heteromer by the A167V
mutation was considered as evidence for its pathogenicity, this
inactivation was observed in Xenopus oocytes, not in mammalian
cells [7–9]. In some mammalian cells, moderate inactivation of
the Kir4.1/Kir5.1 heteromer by the A167V mutation has been ob-
served [7]. These ﬁndings indicate that reduced K+ recycling may
not be the sole cause of renal salt wasting.
Our results showed that the A167V mutation reduced K+ recy-
cling by inhibiting expression of the basolateral K+ channel. The
Kir4.1(A167V) mutant may have low competence for interaction
with MAGI-1, which likely results in the decreased basolateral
expression of the Kir4.1 channel. However, our analysis in
HEK293T cells and the GST-pull-down assays revealed that the
mutation did not reduce competence; indeed, the A167V mutant
interacted with MAGI-1 as well as the wild type. These ﬁndings
support the theory that the mutant can interact with MAGI-1 if
its PDZ-binding motif, the site for the Kir4.1/MAGI-1 interaction,
can contact MAGI-1 [15]. In renal epithelia, MAGI-1 is basolaterally
ﬁxed, and the PDZ-binding motif of Kir4.1 cannot contact MAGI-1
unless Kir4.1 is transported to the vicinity of MAGI-1. Therefore,
basolateral K+ recycling at the DCT was reduced likely because
the A167V mutant was not efﬁciently transported to the site of
MAGI-1 localization. Thus, mistrafﬁcking of the basolateral K+
channel, not reduced competence for the channel to interact with
MAGI-1, underlies the reduction in K+ recycling associated with
the A167V mutation.
Intracellular trafﬁcking of membrane proteins varies by cell
type [23]. Therefore, the Kir4.1 channels that could not be trans-
ported to the basolateral side in renal tubular cells could be trans-
ported to the cell surface in other cells. Further, channels with the
A167Vmutation might be functional in some extrarenal organs. An
A167V homozygote showed hearing loss but no epileptic seizures;
this led to the conclusion that intracellular mistrafﬁcking of
Kir4.1(A167V) may occur in the ear but not in the brain [9]. Fur-
thermore, the phenotypes of various KCNJ10mutations may differ;
some mutations may cause only tubulopathy and thus may be
indistinguishable from Gitelman’s syndrome. Indeed, some forms
of Gitelman’s syndrome may be caused by KCNJ10 mutations that
diminish only renal tubular K+ conductivity.
In conclusion, the basolateral K+-recycling channel in human
DCT is formed by the association of the Kir4.1/Kir5.1 heteromer
with MAGI-1 via the Kir4.1 subunit. Mutations associated with
EAST/SeSAME syndrome decreased the functional expression of
the channel and reduced K+ recycling and thus Na+ reabsorption
at the DCT, which causes renal salt wasting. The pathogenetic
mechanism underlying the reduction in K+ recycling differs with
each causative mutation, and mistrafﬁcking of Kir4.1 in renal epi-
thelia contributed to the loss of K+ recycling in the A167V
mutation.5. Disclosure
All the authors declared no competing interests.
Acknowledgements
This work was supported by Grants-in-Aid for Scientiﬁc Re-
search from the Ministry of Education, Culture, Sports, Science
and Technology of Japan (to M.T. and K.K.). It was also supportedby a grant from the Salt Science Research Foundation (No. 10C2
to M.T.).
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.febslet.2014.
02.024.
References
[1] Bockenhauer, D., Feather, S., Stanescu, H.C., Bandulik, S., Zdebik, A.A., Reichold,
M., Tobin, J., Lieberer, E., Sterner, C., Landoure, G., Arora, R., Sirimanna, T.,
Thompson, D., Cross, J.H., van’t Hoff, W., Al Masri, O., Tullus, K., Yeung, S.,
Anikster, Y., Klootwijk, E., Hubank, M., Dillon, M.J., Heitzmann, D., Arcos-
Burgos, M., Knepper, M.A., Dobbie, A., Gahl, W.A., Warth, R., Sheridan, E. and
Kleta, R. (2009) Epilepsy, ataxia, sensorineural deafness, tubulopathy, and
KCNJ10 mutations. N. Engl. J. Med. 360, 1960–1970.
[2] Scholl, U.I., Choi, M., Liu, T., Ramaekers, V.T., Hausler, M.G., Grimmer, J., Tobe,
S.W., Farhi, A., Nelson-Williams, C. and Lifton, R.P. (2009) Seizures,
sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance
(SeSAME syndrome) caused by mutations in KCNJ10. Proc. Natl. Acad. Sci. USA
106, 5842–5847.
[3] Tanemoto, M., Kittaka, N., Inanobe, A. and Kurachi, Y. (2000) In vivo formation
of a proton-sensitive K+ channel by heteromeric subunit assembly of Kir5.1
with Kir4.1. J. Physiol. 525, 587–592.
[4] Ito, M., Inanobe, A., Horio, Y., Hibino, H., Isomoto, S., Ito, H., Mori, K., Tonosaki,
A., Tomoike, H. and Kurachi, Y. (1996) Immunolocalization of an inwardly
rectifying K+ channel, K(AB)-2 (Kir4.1), in the basolateral membrane of renal
distal tubular epithelia. FEBS Lett. 388, 11–15.
[5] Higashi, K., Fujita, A., Inanobe, A., Tanemoto, M., Doi, K., Kubo, T. and Kurachi,
Y. (2001) An inwardly rectifying K(+) channel, Kir4.1, expressed in astrocytes
surrounds synapses and blood vessels in brain. Am. J. Physiol. Cell Physiol. 281,
922–931.
[6] Hibino, H., Higashi-Shingai, K., Fujita, A., Iwai, K., Ishii, M. and Kurachi, Y.
(2004) Expression of an inwardly rectifying K+ channel, Kir5.1, in speciﬁc
types of ﬁbrocytes in the cochlear lateral wall suggests its functional
importance in the establishment of endocochlear potential. Eur. J. Neurosci.
19, 76–84.
[7] Sala-Rabanal, M., Kucheryavykh, L.Y., Skatchkov, S.N., Eaton, M.J. and Nichols,
C.G. (2010) Molecular mechanisms of EAST/SeSAME syndrome mutations in
Kir4.1 (KCNJ10). J. Biol. Chem. 285, 36040–36048.
[8] Williams, D.M., Lopes, C.M., Rosenhouse-Dantsker, A., Connelly, H.L., Matavel,
A., OU, J., McBeath, E. and Gray, D.A. (2010) Molecular basis of decreased Kir4.1
function in SeSAME/EAST syndrome. J. Am. Soc. Nephrol. 21, 2117–2129.
[9] Parrock, S., Hussain, S., Issler, N., Differ, A.M., Lench, N., Guarino, S., Oosterveld,
M.J., Keijzer-Veen, M., Brilstra, E., van Wieringen, H., Konijnenberg, A.Y., Amin-
Rasip, S., Dumitriu, S., Klootwijk, E., Knoers, N., Bockenhauer, D., Kleta, R. and
Zdebik, A.A. (2013) KCNJ10 mutations display differential sensitivity to
heteromerisation with KCNJ16. Nephron. Physiol. 123, 7–14.
[10] Reichold, M., Zdebik, A.A., Lieberer, E., Rapedius, M., Schmidt, K., Bandulik, S.,
Sterner, C., Tegtmeier, I., Penton, D., Baukrowitz, T., Hulton, S.A., Witzgall, R.,
Ben-Zeev, B., Howie, A.J., Kleta, R., Bockenhauer, D. and Warth, R. (2010)
KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia,
sensorineural deafness, and tubulopathy) disrupt channel function. Proc.
Natl. Acad. Sci. USA 107, 14490–14495.
[11] Tang, X., Hang, D., Sand, A. and Kofuji, P. (2010) Variable loss of Kir4.1 channel
function in SeSAME syndrome mutations. Biochem. Biophys. Res. Commun.
399, 537–541.
[12] Scholl, U.I., Dave, H.B., Lu, M., Farhi, A., Nelson-Williams, C., Listman, J.A. and
Lifton, R.P. (2012) SeSAME/EAST syndrome-phenotypic variability and delayed
activity of the distal convoluted tubule. Pediatr. Nephrol. 27, 2081–2090.
[13] Lourdel, S., Paulais, M., Cluzeaud, F., Bens, M., Tanemoto, M., Kurachi, Y.,
Vandewalle, A. and Teulon, J. (2002) An inward rectiﬁer K(+) channel at the
basolateral membrane of the mouse distal convoluted tubule: similarities
with Kir4-Kir5.1 heteromeric channels. J. Physiol. 538, 391–404.
[14] Tanemoto, M. (2007) Regulatory mechanism of ‘‘K+ recycling’’ for Na+
reabsorption in renal tubules. Clin. Exp. Nephrol. 11, 1–6.
[15] Tanemoto, M., Toyohara, T., Abe, T. and Ito, S. (2008) MAGI-1a functions as a
scaffolding protein for the distal renal tubular basolateral K+ channels. J. Biol.
Chem. 283, 12241–12247.
[16] Tanemoto, M., Abe, T. and Ito, S. (2005) PDZ-binding and di-hydrophobic
motifs regulate distribution of Kir4.1 channels in renal cells. J. Am. Soc.
Nephrol. 16, 2608–2614.
[17] Tanemoto, M., Abe, T., Onogawa, T. and Ito, S. (2004) PDZ binding motif-
dependent localization of K+ channel on the basolateral side in distal tubules.
Am. J. Physiol. Renal. Physiol. 287, F1148–1153.
[18] Tanemoto, M., Fujita, A., Higashi, K. and Kurachi, Y. (2002) PSD-95 mediates
formation of a functional homomeric Kir5.1 channel in the brain. Neuron 34,
387–397.
[19] Derst, C., Karschin, C., Wischmeyer, E., Hirsch, J.R., Preisig-Muller, R., Rajan, S.,
Engel, H., Grzeschik, K., Daut, J. and Karschin, A. (2001) Genetic and functional
linkage of Kir5.1 and Kir2.1 channel subunits. FEBS Lett. 491, 305–311.
M. Tanemoto et al. / FEBS Letters 588 (2014) 899–905 905[20] Gamba, G. (2009) The thiazide-sensitive Na+–Cl cotransporter: molecular
biology, functional properties, and regulation by WNKs. Am. J. Physiol. Renal.
Physiol. 297, F838–848.
[21] Giebisch, G. (2001) Renal potassium channels: function, regulation, and
structure. Kidney Int. 60, 436–445.
[22] Simon, D.B., Nelson-Williams, C., Bia, M.J., Ellison, D., Karet, F.E., Molina, A.M.,
Vaara, I., Iwata, F., Cushner, H.M., Koolen, M., Gainza, F.J., Gitleman, H.J. andLifton, R.P. (1996) Gitelman’s variant of Bartter’s syndrome, inherited
hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-
Cl cotransporter. Nat. Genet. 12, 24–30.
[23] Welling, P.A. and Weisz, O.A. (2010) Sorting it out in endosomes: an
emerging concept in renal epithelial cell transport regulation. Physiology
25, 280–292.
